miR-143 Inhibits NSCLC Cell Growth and Metastasis by Targeting Limk1

被引:49
|
作者
Xia, Hui [1 ]
Sun, Shengjie [2 ]
Wang, Bo [3 ]
Wang, Tao [3 ]
Liang, Chaoyang [3 ]
Li, Guo [3 ]
Huang, Chongbiao [4 ]
Qi, Daliang [4 ]
Chu, Xiangyang [3 ]
机构
[1] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Thorac Cardio Surg, Beijing 100048, Peoples R China
[2] Gen Hosp Peoples Liberat Army, Dept Med Oncol, Beijing 100853, Peoples R China
[3] Gen Hosp Peoples Liberat Army, Dept Thorac Surg, Beijing 100853, Peoples R China
[4] Tianjin Med Univ, Canc Inst & Hosp, Dept Senior Ward, Key Lab Canc Prevent & Therapy Tianjin, Tianjin 300060, Peoples R China
关键词
miR-143; NSCLC; Limk1; proliferation; migration; invasion; LUNG-CANCER CELLS; DOWN-REGULATION; MICRORNA-143; PROLIFERATION; EXPRESSION; MIGRATION; DIAGNOSIS; MOTILITY; INVASION;
D O I
10.3390/ijms150711973
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) have essential roles in carcinogenesis and tumor progression. Here, we investigated the roles and mechanisms of miR-143 in non-small cell lung cancer (NSCLC). miR-143 was significantly decreased in NSCLC tissues and cell lines. Overexpression of miR-143 suppressed NSCLC cell proliferation, induced apoptosis, and inhibited migration and invasion in vitro. Integrated analysis identified LIM domain kinase 1 (Limk1) as a direct and functional target of miR-143. Overexpression of Limk1 attenuated the tumor suppressive effects of miR-143 in NSCLC cells. Moreover, miR-143 was inversely correlated with Limk1 expression in NSCLC tissues. Together, our results highlight the significance of miR-143 and Limk1 in the development and progression of NSCLC.
引用
收藏
页码:11973 / 11983
页数:11
相关论文
共 50 条
  • [1] MiR-143 inhibits endometrial cancer cell proliferation and metastasis by targeting MAPK1
    Chang, Lei
    Zhang, Dongya
    Shi, Huirong
    Bian, Yangyang
    Guo, Ruixia
    ONCOTARGET, 2017, 8 (48) : 84384 - 84395
  • [2] MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1
    Zhou, Jianda
    Liu, Rui
    Luo, Chengqun
    Zhou, Xiao
    Xia, Kun
    Chen, Xiang
    Zhou, Ming
    Zou, Qiong
    Cao, Peiguo
    Cao, Ke
    CANCER BIOLOGY & THERAPY, 2014, 15 (10) : 1340 - 1349
  • [3] miR-195 inhibits the growth and metastasis of NSCLC cells by targeting IGF1R
    Wang, Xiaoli
    Wang, Yuchang
    Lan, Hongwen
    Li, Jun
    TUMOR BIOLOGY, 2014, 35 (09) : 8765 - 8770
  • [4] MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells
    Cui, Guanghui
    Cui, Mingwei
    Li, Yuhang
    Liang, Youguang
    Li, Weihao
    Guo, Haizhou
    Zhao, Song
    TUMOR BIOLOGY, 2014, 35 (09) : 8933 - 8937
  • [5] MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1
    Yu, Hai-Xiang
    Wang, Xiao-Long
    Zhang, Le-Ning
    Zhang, Ji
    Zhao, Wei
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 109 : 751 - 761
  • [6] miR-143 inhibits proliferation and metastasis of nasopharyngeal carcinoma cells via targeting FMNL1 based on clinical and radiologic findings
    Cui, Fusheng
    Ji, Yuqing
    Wang, Man
    Gao, Fengxiao
    Li, Yongcai
    Li, Xueshen
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (10) : 16427 - 16434
  • [7] Dasatinib Inhibits Lung Cancer Cell Growth and Patient Derived Tumor Growth in Mice by Targeting LIMK1
    Zhang, Man
    Tian, Jie
    Wang, Rui
    Song, Mengqiu
    Zhao, Ran
    Chen, Hanyong
    Liu, Kangdong
    Shim, Jung-Hyun
    Zhu, Feng
    Dong, Zigang
    Lee, Mee-Hyun
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [8] miR-27b targets LIMK1 to inhibit growth and invasion of NSCLC cells
    Wan, Li
    Zhang, Lin
    Fan, Kai
    Wang, Jianjun
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2014, 390 (1-2) : 85 - 91
  • [9] miR-27b-3p suppresses cell proliferation, migration and invasion by targeting LIMK1 in colorectal cancer
    Chen, Yun
    Chen, Guojiang
    Zhang, Bing
    Liu, Changfeng
    Yu, Yong
    Jin, Ye
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (09): : 9251 - 9261
  • [10] MiR-539 inhibits cell proliferation and invasion by targeting CARMA1 in NSCLC
    Zhou, Dongbo
    He, Baimei
    Gao, Ying
    Yu, Qiao
    Chen, Qiong
    He, Bixiu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02): : 1460 - 1466